Skip to: Content
Skip to: Site Navigation
Skip to: Search

News Sections

Newser Specials

Cancer Research

Started by S Goldstein; Last updated Feb 25, 08 6:34 PM CST by D Lim | View history

Rate it:

Print

E-mail

|

Digg

Seed this on Newsvine

Add this link to Del.icio.us

StumbleUpon

| Edit thread | Notify editors | + Start a new thread

Cancer Research

The race to stop the disease that kills over 550,000 Americans each year

Stories

Stories 1 - 20 of 127

<< Prev 1 2 3 4 5 ... 7 Next >>

July 2008
- Cancer Researcher Warns of Cell Phone Risks
  
  newser | Pittsburgh Post-Gazette | 1 hour, 8 minutes ago
  
  The chief of a cancer institute in Pittsburgh warned his staff today to take precautions with cell phones because of possible health risks, the Post-Gazette reports. The doctor advised people to keep their calls short, text whenever possible to keep phones away from the head, and limit use among children. The warning appears to be the first from any major cancer center in the US. More »
- Tobacco May Help Cure Cancer
  
  newser | Newsweek | Jul 22, 08 5:39 PM CDT
  
  Scientists are trying to use the tobacco plant to produce a cancer vaccine, Newsweek reports. Ironic though it may be, the plant could someday offer fast and cheap production of antibodies personalized for individual’s tumor cells. In the first study of its kind, scientists found that the plant-based vaccine triggered the immune systems of patients with a type of non-Hodgkin's lymphoma without dangerous side effects. A larger study will now determine how effective the vaccine is at fighting the cancer. More »
- Pill Delivers Prostate Cancer Breakthrough
  
  newser | Reuters | Jul 22, 08 2:07 AM CDT
  
  A new experimental pill taken once a day is proving effective against an advanced, aggressive form of prostate cancer which has resisted other therapies, reports Reuters. The drug, abiraterone, created by Cougar Biotechnology, significantly shrank tumors in a clinical trial, according to a study in the Journal of Clinical Oncology . It could be available by 2011. Prostate cancer is the second-leading cancer killer of men after lung cancer. More »
- Study: Breast Self-Exams Don't Improve Cancer Survival
  
  newser | WebMD | Jul 16, 08 11:55 AM CDT
  
  Breast self-examinations, long recommended to women to detect early signs of breast cancer, serve no purpose, according to a review of the latest research. WebMD reports that 10-year studies of 388,500 women in Russia and China showed no improvement in survival rates from the self-exams, but revealed an added risk of unnecessary biopsies. More »
- Devils Breed Earlier to Stave Off Cancer
  
  newser | Daily Telegraph (UK) | Jul 14, 08 8:46 PM CDT
  
  Tasmanian devils are reproducing at a younger age to offset a contagious cancer epidemic, the Daily Telegraph reports. The ill-tempered marsupials, suffering from tumors that cut their lifespan in half, are now breeding at age 1 instead of 2 or 3. "We could be seeing evolution occurring before our eyes," one expert told the AP—though the devils may still die off in about 25 years. More »
- Popular Cancer Drug Is Iffy and Expensive
  
  newser | New York Times | Jul 6, 08 10:48 AM CDT
  
  Avastin is one of the most widely prescribed cancer drugs in the world, but it might not work, the New York Times reports. The drug, made by Genentech, brings in about $2.3 billion a year in the US alone, but recent trials have shown that though the drug shrinks tumors in sufferers of colon, breast, and lung cancer, it offers little extension of life. More »
June 2008
- Fungus Drug Zaps Cancer in Study
  
  newser | Reuters | Jun 30, 08 6:39 AM CDT
  
  A powerful new cancer drug has been developed from a fungus discovered by accident, Reuters reports. The drug, called lodamin, is dramatically effective against a range of cancers and works by starving tumors of blood, according to a new study published in the journal Nature Biotechnology. Mice infected with cancer cells were nearly cancer free within days. More »
- Gene Test May Rewrite Breast Cancer Screening
  
  newser | Guardian (UK) | Jun 25, 08 7:57 PM CDT
  
  Scientists say they will soon be able to take a simple mouth swab from women to better determine their risk of breast cancer, the Guardian reports. Researchers at Cambridge University have zeroed in on several genetic variants—with more to come—that offer a far more precise measure of a woman's risk than current tests. The development could have a profound impact on current screening procedures and the timeline for mammographies. More »
- Cancer Vaccine Shows Promise
  
  newser | Reuters | Jun 24, 08 5:11 PM CDT
  
  Encouraging results in experiments on mice are raising hopes of an effective colon cancer vaccine, Reuters reports. Capitalizing on the fact that the intestines have their own immune system, researchers isolated a protein that occurs only in the gut to create a vaccine. In treated mice, an average of three tumors appeared in the lungs or liver. In unvaccinated mice, the number was 30. More »
- Lance's Romances Haven't Hurt His Cause—Yet
  
  newser | New York Times | Jun 22, 08 9:50 AM CDT
  
  Will the real Lance Armstrong please stand up? The seven-time Tour de France champ and cancer research advocate is also a serial dater whose affairs light up gossip pages. But so far, trysts with Ashley Olsen and Kate Hudson have not hurt the cancer survivor's higher cause—which includes testifying before Congress and selling 70 million yellow Livestrong bracelets. More »
- Melanoma Cured by Cloning Patient's Own Immune Cells
  
  newser | Scientific American | Jun 19, 08 6:11 AM CDT
  
  Scientists eliminated a man's late-stage melanoma by giving the body's own defenses a massive boost, Scientific American reports. They removed infection-fighting white blood cells from the patient's body, cloned them in the lab until they numbered in the billions, and injected them back into the patient. He was tumor-free 2 months later and remained so for 2 years. More »
- Dying Patients Helped by Docs' End-of-Life Talks
  
  newser | Associated Press | Jun 16, 08 5:51 AM CDT
  
  While only a third of terminally-ill cancer patients received end-of-life talks from their doctors, those who did fared better, a study has found. Doctors who hedge may think they’re protecting their patients, but patients who got the talk were no more likely to get depressed, avoided living their final days in hospitals, and didn’t spend on expensive, futile care, the AP reports. More »
- How Congress Can Help Ted Kennedy
  
  newser | Wall Street Journal | Jun 11, 08 8:00 AM CDT
  
  Ted Kennedy has, at best, about two years to live. A drug exists that might extend his life, but Kennedy, and legions of other cancer sufferers, won’t get it because it hasn’t been through Phase III FDA trials. But congress could yet come to the rescue; a bill recently introduced in the Senate would give the terminally ill access to unproven treatments. More »
- HPV Triggers Throat Cancer Rise, Docs Say
  
  newser | Chicago Tribune | Jun 9, 08 3:12 PM CDT
  
  Researchers believe the virus behind cervical cancer is also responsible for a rash of throat cancers, the Chicago Tribune reports. With baby boomers mainly falling victim to the disease, experts believe the rise in oral sex since the 1960s and '70s could be behind the small-scale epidemic—which could be more prevalent than cervical cancer within a decade. More »
- If Brain Surgeons Only Use Their Cells on Speaker ...
  
  newser | New York Times | Jun 3, 08 2:13 PM CDT
  
  Experts, including the American Cancer Society, say cell-phone use doesn’t increase the risk of cancer. So why do three prominent neurosurgeons avoid holding phones up to their ears? The debate has been reopened, the New York Times reports, by the surgeons’ recent comments on CNN and by Ted Kennedy’s diagnosis with a type of tumor critics associate with cell phones. More »
- Brain Cancer Vaccine Doubles Survival Time
  
  newser | Reuters | Jun 3, 08 11:41 AM CDT
  
  A new vaccine more than doubles the expected survival time of patients with the most common form of brain cancer, Reuters reports. Although the test group was small, patients lived an average of 33 months—"almost unheard of" compared to the average of 14 months, says one doctor. The drug also boosts the body's immune response. More »
- Genes ID Best Patients for Colon Cancer Drug
  
  newser | Reuters | Jun 2, 08 2:46 AM CDT
  
  Researchers have taken a giant step toward the "holy grail" of personalized cancer treatment—by using genetic profiling to accurately target chemotherapy, Reuters reports. A new genetic test of colon cancer tumors is able to predict with accuracy whether a patient will respond to treatment with the drug Erbitux, which blocks tumor growth. More »
May 2008
- Bone Drug Reduces Breast Cancer Relapse
  
  newser | Bloomberg | May 31, 08 7:21 PM CDT
  
  A drug designed to protect cancer patients' bones also renders breast cancer relapses less likely, a new study says. Funded in part by the drug's maker, Novartis, researchers found that even two injections of Zometa a year cut tumor recurrence by 35% in more than 1,800 pre-menopausal women. More »
- Networks Will Partner For Cancer Telethon
  
  newser | New York Times | May 27, 08 4:10 PM CDT
  
  ABC, CBS and NBC have decided to work together to fight cancer, the New York Times reports. Each network's lead news anchor will appear on a Sept. 5 telethon broadcast on all three channels simultaneously. The principles—CBS's Katie Couric, NBC's Brian Williams and ABC's Charlie Gibson—have all lost immediate relatives to cancer. More »
- $600M Windfall Aims to Boost Risky Research
  
  newser | Washington Post | May 27, 08 2:07 PM CDT
  
  American medical research got a big boost today, courtesy of the Howard Hughes Medical Institute. The philanthropic body, one of the world’s largest, committed $600 million to fund the research of 56 scientists that it thinks can change the world. The institute hopes to back high-risk, high-reward research that normal grants wouldn’t touch, the Washington Post reports. More »

Stories 1 - 20 of 127

<< Prev 1 2 3 4 5 ... 7 Next >>

Student medical technologists look through microscopes as they study blood smears from a cancer patient in a Haematology Lab on April 20, 2007 in Singapore. Smoking, drinking and eating unhealthy foods... (Associated Press)

Johns Hopkins Hospital Continues Cancer Research And Treatment (Getty Images)

US NEWS LIVERCANCER 1 MW (KRT Photos)

« Prev« Prev | Next »Next » Slideshow

Related Threads

Medical Breakthroughs • Public Health • So You Like Lists? • Cancer Goes Public • Diet & Exercise • Drug Companies • Food & Drug Safety • Humanity 2.0 • Caffeine Conundrum • Global Mobile

Background

A History of Chemotherapy
chemheritage.org

"In the 1960s, scientists discovered that an extract from the bark of the Pacific yew tree could be used to fight cancer. The substance%u2014Taxol®%u2014is one of the hundreds of naturally occurring substances that people have used for centuries to treat disease and promote health..."

» Read more about A History of Chemotherapy at chemheritage.org

World Health Organization's fact sheet on Cancer
World Health Organization

"Cancer is a generic term for a group of more than 100 diseases that can affect any part of the body. Other terms used are malignant tumours and neoplasms. One defining feature of cancer is the rapid creation of abnormal cells which grow beyond their usual boundaries, and which can invade adjoining...

» Read more about World Health Organization's fact sheet on Cancer at World Health Organization

More Recommend Reading

Professional Organizations and Research

American Association for Cancer Research
AACR.org
The National Cancer Institute
Cancer.gov
The Institute of Cancer Research
IRC.AC.UK
Virtual Cancer Center
VirtualMedicalCentre.com

Support and Advocacy

American Cancer Society
American Cancer Society
AACR's Support and Advocacy Site
AACR.org
Cancer on MedlinePlus
National Institutes of Health
Association of Cancer Online Resources
ACOR.org

Loading...

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.